Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Xenazine current manufacturer 2025?When is the expected fda decision date for apotex's ruxolitinib resubmission?Excipients list used in dexamethasone creams?Complera manufacturer?
See the DrugPatentWatch profile for Sumatriptan
Sumatriptan is classified as a triptan, a prescription medicine used to treat migraine attacks and, in some cases, cluster headaches. It is a serotonin (5-HT) receptor agonist, meaning it activates specific serotonin receptors involved in migraine-related pathways.
As a 5-HT receptor agonist (triptan class), sumatriptan primarily acts on serotonin receptors associated with cranial blood vessels and pain signaling. This class effect is part of why triptans can reduce migraine symptoms once an attack starts.
Clinically, sumatriptan is an acute (abortive) migraine therapy. That means it’s used to stop or lessen symptoms during an attack rather than to prevent migraines long-term.
No. Sumatriptan is not an NSAID (like ibuprofen) and it is not an opioid. Its classification is specifically the triptan/serotonin agonist group used for migraine and cluster headache treatment.
Other Questions About Sumatriptan :